48
FDA Approves Controversial New Opioid 10 times More Powerful than Fentanyl

FDA Approves Controversial New Opioid 10 times More Powerful than Fentanyl

6 years ago
Anonymous $yysEBM5EYi

https://www.scientificamerican.com/article/fda-approves-controversial-new-opioid-10-times-more-powerful-than-fentanyl/

In a highly controversial move, the Food and Drug Administration approved an especially powerful opioid painkiller despite criticism that the medicine could be a “danger” to public health. And in doing so, the agency addressed wider regulatory thinking for endorsing such a medicine amid nationwide angst about overdoses and deaths attributed to opioids.

The drug is called Dsuvia, which is a tablet version of an opioid marketed for intravenous delivery, but is administered under the tongue using a specially developed, single-dose applicator. These “unique features” make the medicine well-suited for the military and therefore was a priority for the Pentagon, a point that factored heavily into the decision, according to FDA Commissioner Scott Gottlieb.

FDA Approves Controversial New Opioid 10 times More Powerful than Fentanyl

Nov 3, 2018, 2:20am UTC
https://www.scientificamerican.com/article/fda-approves-controversial-new-opioid-10-times-more-powerful-than-fentanyl/ > In a highly controversial move, the Food and Drug Administration approved an especially powerful opioid painkiller despite criticism that the medicine could be a “danger” to public health. And in doing so, the agency addressed wider regulatory thinking for endorsing such a medicine amid nationwide angst about overdoses and deaths attributed to opioids. > The drug is called Dsuvia, which is a tablet version of an opioid marketed for intravenous delivery, but is administered under the tongue using a specially developed, single-dose applicator. These “unique features” make the medicine well-suited for the military and therefore was a priority for the Pentagon, a point that factored heavily into the decision, according to FDA Commissioner Scott Gottlieb.